Pharmaceutical

Cytel Unveiled as OneMedNet’s Newest Alliance Partner

Cytel’s software products and services are utilized by hundreds of life science organizations, including the top 30 biopharmaceutical companiesMINNEAPOLIS, July…

6 months ago

Awakn Life Sciences Provides Update on Aminoindane New Chemical Entity Patent Portfolio

Toronto, Ontario--(Newsfile Corp. - July 22, 2024) - Awakn Life Sciences Corp. (CSE: AWKN) (OTCQB: AWKNF) (FSE: 954) ("Awakn" or…

6 months ago

FinnGen Selects Azenta to Propel Personalized Medicine for Population Health Study

Azenta will provide proteomics technology profiling on up to 20,000 individuals. BURLINGTON, Mass., July 22, 2024 /PRNewswire/ -- Azenta, Inc.…

6 months ago

CustomerInsights.AI (CIAI) and Ikigai Labs Announce Strategic Collaboration to Innovate AI Solutions for the Pharmaceutical Industry

SCOTTSDALE, Ariz., July 19, 2024 /PRNewswire/ -- CustomerInsights.AI (CIAI) is excited to announce a strategic collaboration with Ikigai Labs to…

6 months ago

Valinor Pharma Announces Acquisition by Grünenthal with a Total Deal Value of Approximately $250 Million

Grünenthal acquires Valinor Pharma in an all-stock deal and becomes the owner of the global rights to Movantik® (naloxegol)Valinor Pharma…

6 months ago

AmpleLogic Turns 15; Marked in an Evening Filled with Celebrations and Inspiration

HYDERABAD, India, July 22, 2024 /PRNewswire/ -- AmpleLogic, a leader in providing GAMP (Good Automated Manufacturing Practices) solutions, celebrated its…

6 months ago

Elucid Names Kelly Huang as CEO

Experienced commercial leader takes helm to expand cardiovascular diagnostic company globally and commercialize company’s flagship plaque analysis softwareBOSTON--(BUSINESS WIRE)--Elucid, a…

6 months ago

NervGen Pharma Appoints Neil Klompas to Board of Directors

Seasoned pharmaceutical executive with extensive experience in high-growth life sciences companies joins NervGenLeadership appointment supports the company's mission to advance…

6 months ago

MIRA Pharmaceuticals Reveals Preclinical Success: Ketamir-2 Optimized for Brain Delivery, Avoiding Ketamine’s Drug Resistance

New findings highlight potential advantages of MIRA's novel oral ketamine analog for treating neurological and neuropsychiatric disorders MIAMI, FL /…

6 months ago